UNII-30R4R25OEY,
69688-15-9,
30R4R25OEY,
4,5-Dihydromedroxyprogesterone acetate,
Medroxyprogesterone acetate specified impurity F [EP],
4,5-Dihydro-6alpha-methyl-17alpha-hydroxyprogesterone acetate,
6alpha-Methyl-3,20-dioxo-5beta-pregnan-17alpha-yl acetate,
Pregnane-3,20-dione, 17-(acetyloxy)-6-methyl-, (5beta,6alpha)-,
ZINC137723990,
4,5beta-Dihydromedroxyprogesterone Acetate,
(5|A)-4,5-Dihydro Medroxy Progesterone 17-Acetate,
17-(Acetyloxy)-6alpha-methyl-5beta-pregnane-3,20-dione,
[(5S,6S,8R,9S,10S,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate,
6alpha-Methyl-3,20-dioxo-5beta-pregnan-17-yl Acetate (4,5beta-Dihydromedroxyprogesterone Acetate),
Medroxyprogesterone EP Impurity F,
Medroxyprogesterone Acetate Impurity F,
CS-O-13917,
Pregnane-3,20-dione, 17-(acetyloxy)-6-methyl-, (5.beta.,6.alpha.)-,